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Summary
Although the metabolism of dibenzofuran by the bi-
phenyl catabolic enzymes had been inferred in previ-
ous reports, the metabolic pattern has never been de-
termined unambiguously. In this work, we describe
the evolved biphenyl dioxygenase (BPDO) RR41 that
exhibits a higher turnover rate of metabolism toward
dibenzofuran and chlorodibenzofurans than the par-
ental Burkholderia xenovorans LB400 BPDO. We
used RR41 BPDO to identify unambiguously the me-
tabolites produced from the oxygenation of dibenzo-
furan by LB400 BPDO, and we evaluated their further
metabolism by the biphenyl catabolic pathway en-
zymes of strain LB400. RR41 BPDO was obtained by
saturation mutagenesis of targeted amino acid resi-
dues. I335F336N338I341L409 of LB400 BphA were re-
placed by A335M336Q338V341F409 in RR41 BphA. Data
confirm the critical role played by these amino acid
residues for substrate specificity and regiospecificity.
Introduction
The first step of most bacterial oxidative catabolic
pathways involves a hydroxylation reaction to activate
the molecule in order to facilitate further catalytic reac-
tions. Under aerobic conditions, this reaction is often
catalyzed by oxygenases that introduce both atoms of
molecular oxygen directly on vicinal carbons of the
molecule. As an example, biphenyl dioxygenase (BPDO)
catalyzes the first step of the four enzymatic step biphe-
nyl catabolic pathway [1] (Figure 1). It also oxygenates a
range of biphenyl analogs, including polychlorinated bi-
phenyls (PCBs), dibenzofuran, and dibenzodioxin.
When dibenzofuran is the substrate, two types of di-
oxygenation reactions can occur depending on its ori-
entation toward the enzyme catalytic center. When the
vicinal carbons that are oxygenated comprise one of
the two carbons that are bonded to the oxygen atom
of dibenzofuran (4a or 5a), the dioxygenation reaction
is said to be angular (Figure 1). Angular oxygenation
results in a concomitant cleavage of the C-O bond to
generate 2,2#,3-trihydroxybiphenyl [2]. When the dioxy-
genation occurs on vicinal carbons that are not bonded*Correspondence: michel.sylvestre@iaf.inrs.cato the oxygen atom of dibenzofuran, the reaction is said
to be lateral (as for C1-C-2). Lateral oxygenation can
generate three dihydro-dihydroxydibenzofuran isomers.
Several known bacteria can grow on dibenzofuran [2,
3]. These bacteria produce a highly regiospecific dioxy-
genase that catalyzes only the angular oxygenation of
dibenzofuran. The resulting 2,2#,3-trihydroxybiphenyl is
then cleaved by a metapyrochatechase to ultimately
generate salicylic acid [2, 3]. However, no bacteria able
to grow on dibenzofuran through a pathway that in-
volves as a first step a lateral dioxygenation of the sub-
strate has yet been reported. Although lateral oxygena-
tion is not the most desirable mode of attack for
dibenzofuran, the fact that several enzymes were re-
ported to effect this reaction, it is important to know the
regiospecificity of these enzymes toward dibenzofuran
and how the resulting metabolites are further degraded.
Among others, the enzymes of the naphthalene and bi-
phenyl catabolic pathways are likely to be involved in
the cometabolism of dibenzofuran through a lateral ox-
ygenation [4–8], but the pathway (or pathways) involved
has never been elucidated unequivocally. This has an
impact on enzyme engineering because it was shown
that several evolved enzymes exhibiting enhanced met-
abolic activity toward chlorobiphenyls were also shown
to have increased their turnover rates of lateral oxygen-
ation of dibenzofuran [9]. Therefore, in terms of environ-
mental assessment, it is important to elucidate unam-
biguously the various metabolic steps that are likely to
be involved in the further oxidation of the metabolites
generated from lateral dioxygenation of dibenzofuran.
Burkholderia xenovorans strain LB400 [10] (also
called Burkholderia sp. LB400 [11]) produces one of the
best PCB-degrading BPDO of natural origin. BPDO is a
three-component enzyme [12–16] (Figure 1). It com-
prises an iron-sulfur protein (ISPBPH) that catalyzes the
addition of molecular oxygen, a flavoprotein reductase
(REDBPH) and a ferredoxin (FERBPH) that are involved in
the transfer of electrons from NADH to ISPBPH. BPDO
components are coded by bphA (α-subunit of ISPBPH),
bphE (β-subunit of ISPBPH), bphF (FERBPH), and bphG
(REDBPH) in B. xenovorans strain LB400 [10].
B. xenovorans strain LB400 BPDO oxygenates diben-
zofuran inefficiently, principally onto lateral carbons to
generate two dihydro-dihydroxydibenzofurans [7, 17]
whose structures have not yet been determined unam-
biguously. 2,2#,3-trihydroxybiphenyl that resulted from
angular oxygenation is a minor metabolite [7, 17] of
LB400 BPDO. Dibenzofuran is also metabolized by
Pseudomonas sp. NCIB9816-4 naphthalene dioxygen-
ase (NDO) [8]. The enzyme catalyzes lateral dioxygena-
tion of dibenzofuran to yield 1,2-dihydro-1,2-dihydroxy-
dibenzofuran and 3,4-dihydro-3,4-dihydroxydibenzofuran
in a ratio of 61:21. Resnick and Gibson [8] did not report
the presence of 2,2#,3-trihydroxybiphenyl among di-
benzofuran metabolites generated from this NDO. Becher
et al. [4] have shown that biphenyl-induced cells of Ral-
stonia sp. strain SBUG 290 can transform dibenzofuran
to a yellow metabolite identified as 2-hydroxy-4-
(3#-oxo-3#H-benzofuran-2#-yliden)but-2-enoic acid (3#-
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836Figure 1. Biphenyl Catabolic Pathway of
B. xenovorans LB400
The inset shows the structure of dibenzo-
furan indicating the carbon numbering and
the possible oxygenation sites; L indicates
lateral, and A indicates angular.HOBB). This metabolite was presumed to derive from a
the oxidation of 1,2-dihydro-1,2-dihydroxydibenzofuran e
followed by the cleavage of 1,2-dihydroxydibenzofuran t
between carbons 1 and 9b by the biphenyl pathway en- g
zymes [8], but these metabolites were not detected in the 5
growth media. Stope et al. [6] made a similar observation p
showing that 17 Gram-positive biphenyl-degrading iso- B
lates were able to cometabolically transform dibenzo- b
furan to 3#-HOBB during growth on biphenyl. However, P
because 1,2-dihydroxydibenzofuran was transformed a
to a yellow metabolite by cells that were not induced α
by biphenyl [4, 6], the direct involvement of the biphenyl c
catabolic enzymes in this transformation needed further r
confirmation. On the other hand, Seeger et al. [7] have t
shown that incubation of dibenzofuran with an E. coli p
clone expressing bphAEFGBC from LB400 produced a a
yellow metabolite exhibiting a λmax at 464 nm which was a
presumed to be a meta-cleavage compound derived from p
cis-1,2-dihydro-1,2-dihydroxydibenzofuran, but this me-
T
tabolite was not characterized further. Pseudomonas
s
putida G7 harboring plasmid NAH7 [5] that encodes for
othe naphthalene degrading enzymes [18] was also found
Lto transform dibenzofuran to a meta-cleavage metabo-
olite that was identified as trans-2-oxo-4-(3#-hydroxy-
bbenzofuran-2#-yl)-but-3-enoic acid also called 4-[2#-(3#-
Ihydroxy)-benzofuranyl]-2-keto-3-butenoic acid (3#-HBKB).
hThe metabolic intermediate was presumed to be 1,2-
tdihydro-1,2-dihydroxydibenzofuran, but it was not de-
utected in the growth medium. Therefore, although the
3direct participation of the biphenyl or the naphthalene
spathway enzymes in the conversion of 1,2-dihydro-1,2-
idihydroxydibenzofuran has been inferred from several
breports [4, 7], it has never been demonstrated with puri-
Wfied dihydro-dihydroxydibenzofurans and isolated en-
izymes.
dThe substrate specificity of BPDO is crucial because
bit limits the range of compounds potentially degradable
by the catabolic pathway [19]. Its regiospecificity is clso crucial because it will determine whether the next
nzymes of the catabolic pathway can further oxidize
he metabolites that are generated from the initial oxy-
enation of the biphenyl analogs. For example, 2,2#,
,5#- and 2,2#,3,3#-tetrachlorobiphenyl are oxygenated
rincipally onto vicinal meta-para carbons by LB400
PDO to generate metabolites that cannot be cleaved
y 2,3-dihydroxybiphenyl-2,3-dioxygenase (BphC) [20].
revious reports showed that a stretch of seven amino
cids called region III of the C-terminal portion of BPDO
subunit (BphA) strongly influenced the regiospecifi-
ity as well as the turnover rate of reaction toward chlo-
obiphenyls [21, 22]. From random mutagenesis at mul-
iple sites inside region III, we recently obtained variant
4 that exhibited a high turnover rate of reaction toward
range of chlorobiphenyls that LB400 BPDO oxygen-
ted poorly [23]. The amino acid sequence of variant
4 was identical to that of LB400 BPDO except that
335F336 were replaced by A335M336. Preliminary data
howed that this variant had slightly increased its turn-
ver rate of oxygenation of dibenzofuran compared to
B400 BPDO. On the other hand, residue N338 and I341
f region III were also found to influence the range of
iphenyl analogs that the enzyme can oxygenate [23].
n this work, we screened for new variants exhibiting a
igher turnover rate of oxygenation of dibenzofuran
han p4 BphA from a library of variants obtained by sat-
ration mutagenesis of p4 bphA at position 338 and
41. Variant RR41 was obtained, and it produced the
ame metabolites as LB400 BPDO. However, it exhib-
ted a much higher turnover rate of oxygenation of di-
enzofuran and chlorodibenzofurans than LB400 BPDO.
e used the evolved RR41 BPDO to produce and to
dentify unambiguously the two dihydro-dihydroxy-
ibenzofurans generated from the oxygenation of di-
enzofuran by LB400 BPDO. Furthermore, we have
larified the metabolic profile used by the biphenyl
Metabolism of Dibenzofuran
837catabolic enzymes to oxidize these two dihydro-
dihydroxydibenzofurans.
Results
Isolation of Evolved RR41 BPDO and Its Catalytic
Properties toward Dibenzofuran
and Chlorodibenzofurans
Saturation mutagenesis at positions N338 and I341 of
p4 BPDO was performed according to the protocol de-
scribed in Experimental Procedures. In a library of
60,000 E. coli pQE31[bphAE] plus pDB31[bphFGBC]
transformants that were exposed to vapors of dibenzo-
furan, 20 exhibited a deep yellow-orange coloration
that suggested a transformation into a meta-cleavage
metabolite. One of these clones exhibited a clearly
more intense yellow-orange coloration than all others;
it was designated RR41. Sequence analysis indicated
three amino acid substitutions compared to p4 BphA.
They were N338Q, I341V, and L409F.
Resting E. coli cells producing LB400 BPDO oxidized
30 nmol of dibenzofuran in 18 hr [17]. Under the same
conditions, E. coli cells producing variant p4 and RR41
BPDOs metabolized respectively 60 nmol and 150 nmol
dibenzofuran in 18 hr. Two butylboronate-derived dihy-
dro-dihydroxydibenzofurans (metabolite 1 and metabo-
lite 2) were detected at a ratio of 95:5 by GC-MS analy-
sis of cultures producing LB400 BPDO [17] (Figure 2A).
Cultures producing variant p4 and RR41 generated the
same two metabolites 1 and 2 at a ratio of 75:25 and
66:33 for variant p4 and RR41, respectively (Figure 2A).
The relative amount of metabolites 1 and 2 was more
difficult to estimate when they were derived with TMS
for GC-MS analysis because the dihydro-dihydroxydi-
benzofurans were transformed to monohydroxydiben-
zofurans during the analytical procedure (see below).
However, TMS derivation permitted the detection in
both cultures of 2,2#,3-trihydroxybiphenyl that resulted
from angular oxygenation of dibenzofuran (Figure 2B).Figure 2. Metabolites Produced from Dibenzofuran by Recombinant E. coli Cells Producing Variant BPDOs
Total ion chromatograms of (A) the butylboronate-derived metabolites produced from dibenzofuran by E. coli cells expressing LB400 (solid
gray line), RR41 (solid black line), or p4 (dotted line) BPDO and (B) the TMS-derived metabolites produced from dibenzofuran by His-tagged-
purified LB400 (solid gray line) or RR41 (solid black line) BPDO. Induced cell suspensions were incubated with dibenzofuran for 18 hr as
described in Experimental Procedures. The enzyme assay set as described in Experimental Procedures was incubated for 5 min at 37°C.Interestingly, resting E. coli cells producing RR41
BPDO oxidized 45 nmol 2-chlorodibenzofuran and 30
nmol 4-chlorodibenzofuran in 1 hr, whereas under iden-
tical conditions, resting cells producing LB400 BPDO
oxidized negligible amount of these two compounds.
GC-MS analysis of the TMS-derived metabolites showed
that catalytic oxygenation of 2-chlorodibenzofuran gen-
erated 2,2#,3-trihydroxy-6#-chlorobiphenyl as major
metabolite plus two dihydro-dihydroxydibenzofurans
(Figure 3A). Only trace amounts of 2,2#,3-trihydroxy-
6#-chlorobiphenyl were detected in culture producing
LB400 BPDO. Unlike 2-chlorodibenzofuran, 4-chloro-
dibenzofuran was metabolized by RR41 BPDO to prin-
cipally one dihydro-dihydroxy-4#-chlorodibenzofuran with
trace amounts of 2,2#,3-trihydroxy-4#-chlorobiphenyl
(Figure 3B). LB400 BPDO produced only trace amounts
of the dihydro-dihydroxy-4#-chlorodibenzofuran. There-
fore, the presence of a chlorine atom on the dibenzo-
furan molecule significantly influences the enzyme’s re-
giospecificity.
The kinetic properties of His-tagged-purified RR41
BPDO were determined from oxygen consumption
rates measured at various concentrations of dibenzo-
furan or 2-chlorodibenzofuran at pH 6.1 and 37°C.
When biphenyl was the substrate, the specific activity
of the enzyme preparations used for the determination
of the catalytic properties was in the range of 70 to 80
nmol min−1 , nmol−1 BPDO. Under these experimental
conditions, the Km and kcat values were respectively
12.1 M and 0.66 s−1 for dibenzofuran (kcat/Km = 5 ×
104 M−1 , s−1) and 30.5 M and 0.28 s−1 (kcat/Km =
9 × 103 M−1 , s−1) for 2-chlorodibenzofuran. His-tagged-
purified preparations of LB400 BPDO that exhibited a
specific activity toward biphenyl similar to that of RR41
BPDO were not sufficiently active toward dibenzofuran
or chlorodibenzofuran to calculate reliable values for
the enzyme kinetic properties. Therefore, the turnover
rates of reaction of RR41 BPDO toward these two sub-
strates were considerably higher than those of LB400
BPDO.
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838Figure 3. Metabolites Produced from Chlorodibenzofurans by Recombinant E. coli Cells Producing Variant BPDOs
Total ion chromatograms of TMS-derived metabolites produced from (A) 2-chlorodibenzofuran and (B) 4-chlorodibenzofuran by E. coli cells
expressing LB400 (solid gray line) or RR41 (solid black line) BPDO. The mass spectra of the metabolites are also shown in the insets. Two
peaks of dihydro-dihydroxy-chlorodibenzofurans exhibiting very similar mass spectral features were detected for each chlorodibenzofuran,
but only the spectrum corresponding to the major metabolite is shown. Also note that for matter of clarity, the mass spectrum for 2,2#,3-
trihydroxy-4#-chlorobiphenyl is not shown.Identification of Metabolites 1 and 2
pMetabolites 1 and 2 were generated by E. coli cells pro-
ducing variant RR41 BPDO. HPLC-purified metabolite s
T1 was stable at 20°C in acetonitrile, ethyl acetate, or
methanol but the minor metabolite 2 was less stable 2
uand was spontaneously converted to 3-hydroxydiben-
zofuran (see below). a
wAnalysis of the 1H-NMR spectral features identified
metabolite 1 as cis-1,2-dihydro-1,2-dihydroxydibenzo- a
sfuran (Figure 4A). The proton assignments were con-
firmed by proton-proton correlation and heteronuclear d
nmultiple quantum correlation (HMQC) experiments that
showed that the aromatic proton at C9 was involved in t
vthe Overhauser effect (NOE) observed at H1. These
NMR spectral features were identical to those pub- o
wlished for cis-1,2-dihydro-1,2-dihydroxydibenzofuran
produced by catalytic oxygenation of dibenzofuran by z
iPseudomonas sp. strain 9816-4 NDO [8].
The minor metabolite was unstable. At room temper- d
tature, it was rapidly transformed to a monohydroxyl de-
rivative. 1H-NMR analysis of this monohydroxyl com- N
npound identified it as 3-hydroxydibenzofuran (Figure
4C). Only aromatic proton signals were detected. The s
tfact that only two protons of the substituted aromatic
ring were coupled together showed that the compound c
could only be 2-hydroxydibenzofuran or 3-hydroxydi-
benzofuran. Heteronuclear multiple bond correlation c
t(HMBC) and HMQC experiments showed a correlation
between the proton H2 at 6.88 ppm (on C2) and the car- j
fbon C9b at 117 ppm, which confirms the position of H2
on carbon C2. Thus, the degradation product of metab- f
(olite 2 was 3-hydroxydibenzofuran.When NMR analysis was performed on a freshly pre-
ared preparation of metabolite 2, about 25% of the
ignals detected were from 3-hydroxydibenzofuran.
he remaining signals allowed us to identify metabolite
as cis-3,4-dihydro-3,4-dihydroxy-dibenzofuran (Fig-
re 4B). The two vinyl protons H1 at 6.62 ppm and H2
t 5.84 ppm were strongly coupled together, and they
ere coupled to only one of the methine protons (H3)
t 4.66 ppm. These features give only two possible
tructures: 1,2-dihydro-1,2-dihydroxydibenzofuran or 3,4-
ihydro-3,4-dihydroxydibenzofuran. Because the sig-
als obtained from metabolite 2 in deuterated acetoni-
rile exhibited chemical displacements and coupling
alues that differed significantly from the NMR spectra
f metablite 1 taken in the same solvant, metabolite 2
as identified as cis-3,4-dihydro-3,4-dihydroxydiben-
ofuran (Figure 4B). These NMR spectral features were
dentical to those published for cis-3,4-dihydro-3,4-
ihydroxydibenzofuran produced by catalytic oxygena-
ion of dibenzofuran by Pseudomonas sp. strain 9816-4
DO [8]. cis-3,4-dihydro-3,4-dihydroxydibenzofuran was
ot reported to be unstable by these authors, but its
tructure was established from NMR analysis of a mix-
ure of cis-1,2-dihydro-1,2-dihydroxydibenzofuran and
is-3,4-dihydro-3,4-dihydroxydibenzofuran [5].
Both metabolites 1 and 2 were not stable under our
ondition of TMS derivatization, both of them were
ransformed to two monohydroxyl derivatives. The ma-
or compound obtained from metabolite 2 (accounting
or 95% of the total substrate converted) was con-
irmed by NMR analysis to be 3-hydroxydibenzofuran
not shown). The ratio of the two monohydroxydi-
Metabolism of Dibenzofuran
839Figure 4. Structural Features of Hydroxylated
Metabolites Derived from Catalytic Dioxy-
genation of Dibenzofuran
Structure of (A) cis-1,2-dihydro-1,2-dihy-
droxydibenzofuran, (B) cis-3,4-dihydro-3,4-
dihydroxydibenzofuran, (C) 3-hydroxydiben-
zofuran, and their NMR coupling constants.benzofuran produced from metabolite 1 was also 95:5.
The precise position of the hydroxyl group on these
compounds was not determined, but their retention
time differed from that of 3-hydroxydibenzofuran and
4-hydroxydibenzofuran produced from cis-3,4-dihydro-
3,4-dihydroxydibenzofuran (see Figure 2B). However,
the proportion of metabolite 1 or 2 that was converted
to corresponding monohydroxydibenzofurans was vari-
able, and we were unable to identify the factors (pH,
temperature, concentration of dihydro-dihydroxydiben-
zofuran, etc.) that were responsible for this variation.
Nevertheless, the erratic conversion of the dihydro-
dihydroxydibenzofurans into monohydroxydibenzofur-
ans during the TMS derivation reaction, indicates that
the GC-MS analysis of TMS-derived dibenzofuran me-
tabolites should be used with caution to examine the
regiospecificity.
Metabolism of cis-1,2-Dihydro-1,2-
Dihydoxydibenzofuran and cis-3,4-Dihydro-3,4-
Dihydroxydibenzofuran
We have used purified His-tagged 2,3-dihydro-2,3-
dihydroxybiphenyl-2,3-dehydrogenase (BphB) and
BphC to verify their capacity to oxidize the HPLC-puri-
fied cis-1,2-dihydro-1,2-dihydoxydibenzofuran and cis-
3,4-dihydro-3,4-dihydroxydibenzofuran. The kineticproperties of BphB toward cis-1,2-dihydro-1,2-dihy-
doxydibenzofuran were calculated at 25°C and at pH
9.0. The Km value was 72.2 M and the kcat value was
1.7 s−1. The calculated kcat/Km value of 2.4 × 104 M−1 ,
s−1 is only eight times less than the reported specificity
constant of LB400 BphB toward 1,2-dihydroxynaphta-
lene [24], which is considered to be a good substrate
for the enzyme. This shows the effectiveness of BphB
to oxidize cis-1,2-dihydro-1,2-dihydoxydibenzofuran.
When BphB assay was run for less than five min, 1,2-
dihydroxydibenzofuran was detected by GC-MS analy-
sis (Figure 5A), but no metabolite was detected when
the reaction was prolonged for longer periods. Hammer
et al. [25] reported the production of 2,3-dihydroxy-
dibenzofuran from the fungal transformation of diben-
zofuran and did not notice that this metabolite was un-
stable. However, based on its structural similarity with
1,2-dihydroxynaphtalene, it is likely that under our as-
say conditions, 1,2-dihydroxydibenzofuran was nonen-
zymatically autooxidized to a quinone derivative [26]
that could not be detected by GC-MS analysis. Purified
preparations of LB400 His-BphB oxidized cis-3,4-dihy-
dro-3,4-dihydroxydibenzofuran to 3,4-dihydroxydiben-
zofuran that was detected by GC-MS analysis (Figure
5B). Because HPLC-purified cis-3,4-dihydro-3,4-dihy-
droxydibenzofuran was rapidly transformed to 3-hydroxy-
Chemistry & Biology
840Figure 5. Catalytic Dehydrogenation of Dibenzofuran Metabolites by LB400 BphB
(A) Total ion chromatogram of TMS-derived 1,2-dihydroxydibenzofuran produced from cis-1,2-dihydro-1,2-dihydroxydibenzofuran by His-
tagged-purified LB400 BphB.
(B) Total ion chromatogram of TMS-derived 3,4-dihydroxydibenzofuran produced from cis-3,4-dihydro-3,4-dihydroxydibenzofuran by His-
tagged-purified LB400 BphB. Solid line, extract from the reaction vial; dashed line, extract from a control reaction without NAD. The assays
were preformed as described in Experimental Procedures. The conversion of the substrate into mono-hydroxydibenzofurans during TMS
derivatization was erratic, which explains why cis-3,4-dihydro-3,4-dihydroxydibenzofuran was only partially transformed to 3-hydroxydibenzo-
furan in the control of chromatogram B. The mass spectra of the TMS-derived 1,2-dihydroxydibenzofuran and 3,4-dihydroxydibenzofuran are
also shown. Diagnostically important spectral features are: m/z = 344 M+, m/z = 329 (M-15), m/z = 256 (M-Me4Si), and m/z = 226
(M-Me4Si-Me2).dibenzofuran, it was not possible to use these prepara- 1
ztions for establishing the catalytic properties of BphB.
However, when approximately 20 nmol of an HPLC- m
3purified preparation of cis-3,4-dihydro-3,4-dihydroxydi-
benzofuran was added to an enzyme assay containing e
i0.6 nmol His-tagged-purified BphB and 100 nmol NAD,
an equivalent amount of NADH was produced after qmin incubation at 37°C. This suggests that the en-
yme oxidized 20 nmol of substrate completely within 1
in of incubation. Similar to 1,2-dihydroxydibenzofuran,
,4-dihydroxydibenzofuran was also unstable under our
nzymatic conditions, and it disappeared rapidly after
ts formation, suggesting that it was autooxidized to a
uinone.
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formed 1,2-dihydro-1,2-dihydroxyxydibenzofuran into a
deep yellow-orange metabolite that exhibited a λmax of
462 at pH 7.0. Its λmax shifted from 420 to 462 nm by
varying the pH from 3.5 to 7.5. This shift was similar to
the one reported for 3#-HOBB [4]. The ring cleavage of
1,2-dihydroxydibenzofuran between C-1 and C-9b can
generate two distinct metabolites: 3#-HOBB was the
ring-cleavage metabolite produced from dibenzofuran
by Ralstonia sp. SBUG 290 [4], and 3#-HBKB was the
ring-cleavage metabolite produced by P. putida G7 [5].
When the yellow metabolite produced from purified
BphC was derived with TMS, two peaks, detected by
GC-MS analysis (Figure 6), exhibited spectral features
characteristic of meta-cleavage metabolites reported
previously [27, 28]. In these instances, cis and trans iso-
mers were produced that arose from the rearrangement
of the meta-cleavage metabolite after the enzymatic re-
action [27]. This is supported by Becher et al [4]. NMR
data showed that 3#-HOBB spectra exhibited a very dif-
fuse resonance of the methylene protons, indicating
that the metabolite isomerized after the enzyme reac-
tion. Data do not permit the unambiguous identification
of the meta-cleavage metabolite. It could either be cis-
trans isomers of 3#-HBKB or 3#-HOBB. Nevertheless,
the presence of a fragmentation ion at m/z = 333
(M-CH3-CO) (Figure 6) is a characteristic feature of a
number of α-monohydroxy acid TMS derivatives [27],Figure 6. Meta-Cleavage Metabolites of Dibenzofuran
The figure shows total ion chromatograms of the meta-cleavage metabolites produced from 1,2-dihydroxydibenzofuran by BphC (dashed
line) and 3,4-dihydroxydibenzofuran by NahC (solid line) and their mass spectra. The meta-cleavage metabolites were produced from the
dihydro-dihydroxydibenzofuran by a coupled reaction involving BphB plus BphC or BphB plus NahC as indicated in the text. Only one of the
two possible isomers produced from the meta-cleavage of 1,2-dihydroxydibenzofuran or 3,4-dihydroxydibenzofuran are shown. Diagnostically
important ions are at m/z = 376 (M+), m/z = 361 (M-CH3), m/z = 333 (M-CH3-CO), and m/z = 259 (M-COOTMS).suggesting that the metabolite is more likely the 3#-
HOBB.
Together, these data show that the biphenyl degrad-
ing enzymes of LB400 can transform dibenzofuran into
at least two meta-cleavage metabolites. One of which
is the 2-hydroxy-6-oxo-6-[2#-hydroxybiphenyl]-hexa-
2,4-dienoic acid [28] resulting from the cleavage of
2,2#,3-trihydroxybiphenyl (see Figure 7), and the other
is most likely 3#-HOBB that derived from the cleavage
of 1,2-dihydroxydibenzofuran. On the other hand, when
cis-3,4-dihydro-3,4-dihydroxydibenzofuran was used in
a coupled reaction with BphB and BphC, no meta-
cleavage metabolite was produced in the reaction me-
dium. However, because variant RR41 was found to
produce proportionately much more 3,4-dihydro-3,4-
dihydroxydibenzofuran than LB400 BPDO, 3,4-dihy-
droxydibenzofuran is expected to accumulate in the
catalytic process. For this reason, we have verified the
capacity of 1,2-dihydroxynaphthalene dioxygenase
(NahC) to cleave 3,4-dihydroxydibenzofuran. NahC is a
dioxygenase homologous to BphC that is involved in
the naphthalene catabolic pathway. When a coupled re-
action involving BphB plus NahC was used to catalyze
the oxidation of cis-3,4-dihydro-3,4-dihydroxydibenzo-
furan, the substrate was converted into a yellow metab-
olite whose spectral features exhibited a λmax of 420
nm. However, there was no pronounced pH-dependent
shift. GC-MS analysis of its TMS derivative (Figure 6)
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842Figure 7. Scheme Showing the Profile of Me-
tabolites Generated during the Oxidation of
Dibenzofuran by the Biphenyl Catabolic En-
zymes of B. xenovorans LB400
Larger arrows show the major metabolic
pathway. The scheme also shows the meta-
cleavage reaction of 3,4-dihydroxydibenzo-
furan that only NahC can catalyze.showed two peaks that are likely to represent the cis d
tand trans isomers of either 2-hydroxy-4-(2#-oxo-2#
H-benzofuran-3#-yliden)but-2-enoic acid (2#-HOBB) or t
s4-(3#-(2#-hydroxy)-benzofuranyl)-2-keto-3-butenoic
acid (2#-HBKB). These would result from a cleavage be- i
itween C-4 and C-4a of the 3,4-dihydroxydibenzofuran.
A ring cleavage between C-2 and C-3 would have gen- T
aerated 2-(1-carbonyl methylidene)-2,3-dihydrobenzo-
furanylidene-glycolic acid (CMDFG) (see Figure 7). a
wBased on the mass spectral features of the methyl-
derived CMDFG that has been reported [25], the ion t
tfragmentation pattern of its TMS derivative should have
included an ion at m/z = 244 (M-CH3COOTMS), which m
cis absent from the spectra shown in Figure 6. Similar to
above considerations, the presence of a fragmentation c
oion at m/z = 333 (M-CH3-CO) (Figure 6) suggests that
the metabolite is more likely to be the 2#-HOBB. It is p
fworth mentioning that 1,2-dihydro-1,2-dihydroxynaph-
thalene dehydrogenase, the enzyme homologous to h
eBphB in the naphthalene catabolic pathway can re-
place BphB in the coupled reaction used to generate s
bHOBB and HBKB from cis-1,2-dihydro-1,2-dihydroxydi-
benzofuran and cis-3,4-dihydro-3,4-dihydroxydibenzo- i
furan. Furthermore, NahC can replace BphC to produce
HOBB from 1,2-dihydroxydibenzofuran (not shown). b
iTherefore, the enzymes of the naphthalene catabolic
pathway metabolize the two dihydro-dihydroxydiben- p
tzofurans resulting from lateral oxygenation of dibenzo-
furan by LB400 BPDO. 1
3
lDiscussion
t
HSphingomonas sp. HH69 [2] with few other bacteria are
able to grow on dibenzofuran. The dioxygenases pro- zuced by these strains are highly regiospecific toward
he angular carbons of dibenzofuran to generate 2,2#,3-
rihydroxybiphenyl, which can be further oxidized to
alicylic acid [2]. It is noteworthy that the genes encod-
ng the enzymes involved in dibenzofuran degradation
n those strains are scattered on their genome [2, 3, 29].
his might suggests that bacteria have not yet evolved
mature dibenzofuran catabolic pathway comprised of
well-organized operon to control all the genes that
ere acquired from patchwork assemblages of por-
ions of pathways. Nojiri and Omori [3] pointed out that
he length of exposure to dibenzofuran in the environ-
ent or the rarity of the genes indispensable for its
omplete degradation might explain why dibenzofuran
atabolic pathways have not yet reach a high level of
rganization. The same arguments can be used to ex-
lain why no bacterial strain able to grow on dibenzo-
uran through a pathway involving lateral dioxygenation
as yet been reported. A better understanding of the
nzymatic steps that would be involved in this pathway
hould help design strategies to construct engineered
acteria able to degrade this persistent pollutant and
ts chlorinated derivatives more efficiently.
In this work, we investigated the metabolism of di-
enzofuran by B. xenovorans LB400, which is a natural
solate that can cometabolize this substrate through a
athway involving lateral dioxygenation. Data showed
hat dioxygenation on the lateral carbons produced cis-
,2-dihydro-1,2-dihydroxydibenzofuran as major plus cis-
,4-dihydro-3,4-dihydroxydibenzofuran as minor metabo-
ites. Both of these metabolites were oxidized by BphB,
he second enzyme of the biphenyl catabolic pathway.
owever, although BphC cleaved 1,2-dihydroxydiben-
ofuran, it was unable to cleave 3,4-dihydroxydibenzo-
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843furan. A more complete oxidation of dibenzofuran by
bacteria expressing LB400 BPDO or engineered en-
zymes derived from it would require an enzyme that can
cleave 3,4-dihydroxydibenzofuran. It is interesting that
NahC can effect this reaction. Several other examples
[20, 30] demonstrated that 1,2-dihydroxynaphthalene
dioxygenase is more versatile than BphC to cleave the
dihydroxylated metabolites produced from biphenyl an-
alogs. The profile of metabolites generated during the
oxidation of dibenzofuran by the enzymes of the biphe-
nyl catabolic pathway is shown in Figure 7. Also shown
is the likely catabolic pathway that an engineered bac-
teria carrying an evolved BPDO effecting lateral dioxy-
genation of dibenzofuran plus the naphthalene degrad-
ing enzyme NahC would follow to oxidize dibenzofuran.
It is noteworthy that DoxG (an enzyme homologous to
NahC) cleaved 3,4-dihydroxybiphenyl in two ways,
either between C-2 and C-3 or between C-4 and C-5
[30]. In this work, NahC cleaved 3,4-dihydroxydibenzo-
furan in only one way: the cleavage occurred between
C-4 and C-4a, which is the position that most closely
resembles the cleavage position of 1,2-dihydroxynaph-
thalene.
Our data showed that the meta-cleavage metabolites
obtained from 1,2-dihydroxydibenzofuran or 3,4-dihy-
droxydibenzofuran were not further degraded by the
hydrolase of 2-hydroxy-6-oxo-6-phenyl-hexa-2,4-die-
noic acid (BphD). Becher et al. [4] showed that salicylic
acid was produced from 3#-HOBB by cultures of Ral-
stonia sp. SBUG 290. However, they were unable to
show the direct involvement of the biphenyl catabolic
enzymes in this transformation. In this context, identi-
fying the enzyme from strain SBUG 290 that oxidized
3#-HOBB to salicylic acid would be of great interest to
design engineered bacteria that degrade dibenzofuran
efficiently.
It is noteworthy that Selifonov et al. [5] identified 3#-
HBKB as the sole meta-cleavage metabolite produced
from dibenzofuran when P. putida G7 cells harboring
the naphthalene degrading plasmid NAH7 were used to
catalyze its oxidation. 3#-HBKB Should have arisen
from the cleavage of 1,2-dihydroxydibenzofuran. Be-
cause we found that NahC obtained from NAH7 plas-
mid can cleave both 1,2-dihydroxydibenzofuran and
3,4-dihydroxydibenzofuran, the data of Selifonov et al.
[5] indicate that the NAH7 plasmid-encoded NDO pro-
duces only small amounts of 3,4-dihydro-3,4-dihydroxy-
dibenzofuran, if at all. This would be in contrast to the
Pseudomonas NCIB 9816-4-encoded NDO, which was
found to generate a mixture of 1,2- and 3,4-dihydro-
dihydroxydibenzofuran at a ratio of 61:21 (approxi-
mately 3:1) [8]. There is 97% sequence identity between
the α subunit of these two NDOs.
Thus, small structural variations of these oxygenases
could be responsible for this difference. For example,
replacing T335F336 of LB400 BphA by A335M336 have cre-
ated a more relaxed variant, p4 characterized by an al-
tered regiospecificity toward 2,2#-dichlorobiphenyl [20].
Data suggested that interactions between specific
amino acids of BphA and the chlorine substituents of
the chlorobiphenyl modulate the orientation that the
substrate can take inside the catalytic pocket. Based
on the crystal structure of Rhodococcus sp. strain
RHA1 BPDO [31], residue I326 of RHA1 BphA1 that cor-responds to F336 of LB400 BphA and M336 in RR41
BphA makes a direct contact with the biphenyl mole-
cule in the crystal structure of RHA1 BPDO. In this re-
gard, position 335 and 336 of BphA were shown to be
critical to determine the orientation of 2,2#-dichlorobi-
phenyl inside the catalytic pocket. On the other hand,
alteration of positions N338I341 of p4 BphA to Q338V341
did not change the regiospecificity of the resulting
RR41 variant BphA toward 2,2#-dichlorobiphenyl (not
shown). These amino acids do not contact the biphenyl
ring in RHA1 BphA1 model. However, the evolved RR41
BPDO exhibited a higher turnover rate of reaction to-
ward dibenzofuran and chlorodibenzofurans than p4
and LB400 BPDOs. Similarly, residue 376 of P. pseudo-
alcaligenes KF707 BphA1 (corresponding to 377 of
LB400 BphA) was also critical to modulate enzyme ac-
tivity toward dibenzofuran [9]. Similar to above amino
acids, the amino acid corresponding to residue 376 of
LB400 BphA does not contact the biphenyl ring in the
RHA1 BphA1 model, but its neighbor does. Therefore,
regiospecificity can be modulated by amino acid resi-
dues other than the ones that interact directly with the
biphenyl ring.
Structural analysis of RHA1 BPDO revealed that the
two rings of the biphenyl molecule are not coplanar but
skewed inside the catalytic pocket of the enzyme [31],
each being fixed from both sides through interactions
with specific amino acids of the enzyme, one of which
being L323 of RHA1 BphA1 (L333 of LB400 BphA). Diben-
zofuran can be regarded as an analog of the symmetri-
cal doubly ortho substituted 2,2#-dichlorobiphenyl.
However, the bonds between the oxygen atom and the
two ortho carbons lock both phenyl rings into a copla-
nar configuration. Therefore, dibenzofuran should posi-
tion quite differently than biphenyl inside the enzyme
catalytic pocket. This might explain why the presence
of a single chlorine atom on one of the rings consider-
ably influences the regiospecificity toward these sub-
strates. Thus, RR41 have acquired the capacity to oxy-
genate 4-chlorodibenzofuran and 2-chlorodibenzofuran
more efficiently than the parental enzyme, but the regi-
ospecifity toward these two substrates differed signifi-
cantly. Nevertheless, it is interesting to point out that
2-chlorodibenzofuran is oxygenated principally onto
angular carbons to produce 2,2#,3-trihydroxy-6#-chlo-
robiphenyl, which should be further transformed to
5-chlorosalicylate by the biphenyl catabolic pathway.
This indicates that an engineered bacteria producing
RR41 BPDO plus BphB, BphC, and BphD from LB400
would oxidize 2-chlorodibenzofuran to its benzoate in-
termediate more efficiently than dibenzofuran, which
would require the participation of enzymes of other cat-
abolic pathways.
Significance
Aryl hydroxylating dioxygenases are promising en-
zymes for numerous industrial and environmental ap-
plications. These enzymes can be engineered to cata-
lyze the oxygenation of many substrate analogs.
Understanding how amino acids of the enzyme cata-
lytic pocket interact with substrate analogs to posi-
tion them toward the enzyme active center will have
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Abetter-performing enzymes. Achieving this goal will
crequire that the identity of the metabolites generated
lby these engineered enzymes be unambiguously de- m
termined. Applying engineered enzymes to environ- D
smental processes will also require that we determine
2unequivocally how the metabolites resulting from ca-
ptalytic oxygenation of new enzyme substrates are fur-
sther metabolized by downstream enzymes. In this
m
work, we have investigated the metabolism of diben- B
zofuran with RR41, an evolved BPDO that oxygenates f
dibenzofuran and chlorodibenzofurans at much higher
turnover rate than the parent B. xenovorans LB400 A
tBDO. Several reports dealt with dibenzofuran metabo-
Alism by the enzymes involved in the catabolism of bi-
cphenyl and naphthalene. However, the metabolism of
bdibenzofuran by the biphenyl catabolic enzymes has
[
never been established unequivocally. We have puri- o
fied the metabolites obtained from catalytic oxygena- t
ttion of dibenzofuran by RR41 BPDO, and we have un-
aambiguously identified them by NMR. The purified
ccompounds were used to verify their metabolism by
wthe enzymes of the biphenyl and naphthalene cata-
sbolic pathways. Our data allow proposing an engi- p
neered dibenzofuran catabolic pathway based on the w
lbiphenyl catabolic enzymes B. xenovorans LB400
Tand the naphthalene catabolic pathway enzymes en-
3coded by plasmid NAH7.
l
tExperimental Procedures
g
RBacterial Strains, Plasmids, Chemicals, and General Protocols
lEscherichia coli DH11S [32], C41(DE3) [33], and XL10-Gold (Stata-
ugene, La Jolla, CA) were used in this study. Plasmids pQE31
a[LB400-bphAE], pQE31[p4-bphAE], pDB31[LB400-bphFG], pDB31
o[LB400-bphFGBC], pQE31[NAH7-nahB], pQE31[NAH7-nahC], and
apQE31[LB400-bphC] were described previously [15, 21, 23]. To pre-
(pare pQE31[LB400-bphD], LB400 genomic DNA was PCR amplified
Iwith the following two primers: 5#-AGGATCCGACCGCACTCACC
tGAAAG-3# and 5#-GACGGTACCTTACGCGTGCCGCAG-3#. The 861
rbp BamHI/KpnI DNA fragment was then ligated into the previously
BamHI/KpnI-digested pQE31 plamid. pQE31[LB400-bphD] was
ucloned into E. coli XL10-Gold. DNA general protocols were done
eaccording to Sambrook et al. [34]. DNA was sequenced at the
tGenome Quebec DNA sequencing center (Montréal, Québec,
MCanada).
s
bPreparation of DNA, Saturation Mutagenesis,
aand Screening Protocols to Evolve BphA
tThe two-step saturation mutagenesis protocol described by Saka-
omoto et al. [35] was used to simultaneously mutate positions N338
sand I341 of variant p4 bphA except that the two DNA fragments
Lthat overlapped inside the p4 bphA region to be mutated (994–1041
cbp) were treated with the Klenow fragment before amplification by
gPCR. pQE31[p4-bphAE] DNA was used to mutate p4-bphA. Primer
z1041R (5#-GGGACCACGCGGGTGCCANNNCCGGATNNNGTTCAT
fAGC-3#) was used in conjunction with primer 1F (5#-CGGGATCCG
cATGAGTTCAGCAATCA-3#) to amplify the first 1041 nucleotides
nof bphA. Primer 994F (5#-TTCCTGCCCGCTATGAACNNNATCCGG
NNN-3#) was used in conjunction with the reverse primer 2059R
(5#-GGTACCCCCTAGAAGAACATGCT-3#) to amplify a 1065 bp DNA M
afragment that corresponded to the right end portion of bphA (start-
ing at 994 bp) plus a portion of bphE. The two fragments were b
Pcombined, assembled with the Klenow fragment, and then ampli-
fied by PCR with the antisense oligonucleotides 367F (5#-ACG P
tGCTGGGCCTACGACATC-3#) and 1601R (5#-CTGCGCTTCGCGG
TAGTAGAACTGC-3#). The resulting 1234 DNA fragment was di- e
tgested with MluI and AvrII to generate a library of 864 bp MluI/AvrII
fragments that was ligated to pQE31[LB400-bphAE] previously de- aeted from its MluI/AvrII fragment. Expand DNA polymerase (Roche
pplied Science) was used. The PCR conditions were set as re-
ommended by the company except that the program was as fol-
ows for 35 cycles: 95°C for 45 s, 60°C for 45 s, and 72°C for 1.5
in. The resulting library of plasmids was transformed into E. coli
H11S pDB31[LB400-bphFGBC] cells, which expressed the entire
et of genes required to convert biphenyl into the yellow-colored
-hydroxy-6-oxo-6-phenylhexa-2,4-dienoic acid. The screening
rotocol described by Barriault and Sylvestre [23] was used to
creen the variants that transformed dibenzofuran into a yellow
etabolite. The assumption was made that clones expressing
PDO variants producing higher levels of hydroxylated dibenzo-
uran metabolites should produce a more intense yellow coloration.
ssays to Identify Dibenzofuran Metabolites and to Quantify
he Catalytic Activity of the BPDOs
ssays to identify dibenzofuran metabolites produced by resting
ells of E. coli were performed according to the protocol described
y L’Abbée et al. [17]. IPTG-induced E. coli [pDB31bphFG] +
pQE31 LB400-bphAE], E. coli [pDB31bphFG] + [pQE31 p4-bphAE],
r E. coli [pDB31bphFG] + [pQE31 RR41-bphAE] were used in
hese assays. The resting cell suspensions were extracted at neu-
ral pH with ethyl acetate. The ethyl acetate was evaporated under
stream of nitrogen, and the residues were directly used for gas
hromatography-mass spectrometry (GC-MS) analysis or they
ere dissolved in a mixture of water:acetonitrile (80:20 v/v). This
olution was injected onto a semipreparative Zorbax-ODS reverse-
hase column (9.4 mm by 25 cm). The column was equilibrated
ith water-acetonitrile (80:20). The compounds were eluted with a
inear gradient to water-acetonitrile (20:80) in 20 min at 0.7 ml/min.
he Agilent model 1314 variable wavelength detector was set at
07 nm, which was previously determined to be the maximal wave-
ength of the dihydro-dihydroxydibenzofuran metabolites. Using
his system, the two dihydro-dihydroxydibenzofuran metabolites
enerated from dibenzofuran by E. coli [pDB31bphFG] + [pQE31
R41-bphAE] eluted as distinct peaks. These peaks were col-
ected, the solvent phase was evaporated in vacuum, and the resid-
al aqueous phase was extracted with ethyl acetate. The identity
nd purity of the metabolites were confirmed by GC-MS analyses
f their butylboronate (nBuB) or N,O-bis-trimethylsilyl trifluoroacet-
mide (TMS) derivatives [24, 28]. Nuclear magnetic resonance
NMR) spectra were obtained at the NMR spectrometry center of
NRS-Institut Armand-Frappier with a Brucker 500 mHz spectrome-
er. The analyses were carried out in deuterated acetonitrile at
oom temperature.
Reconstituted His-tagged-purified BPDO preparations were
sed in some experiments. The protocol to produce and purify the
nzyme components were described previously [20, 21] except
hat LB400 and RR41 bphAE were cloned into pET-14b (Novagen,
adison, WI) and expressed in E. coli C41(DE3). The enzyme as-
ays were performed in 50 mM morpholineethanesulfonic (MES)
uffer (pH 5.5 or pH 6.1) as described previously [19, 20]. Catalytic
ctivities were determined from measurement of substrate deple-
ion recorded by GC-MS analysis or from measurement of NADH
xidation recorded by fluorometry according to the protocols de-
cribed previously [19, 36]. The steady-state kinetic parameters of
B400 and RR41 BPDOs were determined by recording the oxygen
onsumption rates with a Clarke-type Hansatech model DW1 oxy-
raph [37] for concentrations of dibenzofuran and 2-chlorodiben-
ofuran varying between 2.5 to 50 M. The reactions were per-
ormed in MES 50 mM (pH 6.1) buffer at 37°C in a volume of 400 l
ontaining 1.2 nmol of each of the enzyme component and 200
mol NADH.
etabolism of 1,2-Dihydro-1,2-Dihydroxydibenzofuran
nd 3,4-Dihydro-3,4-Dihydroxydibenzofuran
y BphB, BphC, and NahC
urified preparations of B. xenovorans LB400 BphB and BphC and
. putida G7 NahC were used to assess their ability to metabolize
he dihydro-dihydroxydibenzofuran metabolites. The procedures to
xpress these enzymes in recombinant E. coli cells and to purify
hem have been described previously [15, 24]. BphB assays with,
s a substrate, HPLC-purified cis-1,2-dihydro-1,2-dihydroxydiben-
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845zofuran or cis-3,4-dihydro-3,4-dihydroxydibenzofuran were per-
formed in 500 l 50 mM MES buffer (pH 7.0) containing 120 nmol
NAD. The kinetic parameters (Km and kcat) were determined for cis-
1,2-dihydro-1,2-dihydroxydibenzofuran with concentrations between
8 and 120 nM of substrate. The catalytic activity was measured
by recording NADH production fluorometrically with an excitation
wavelength of 340 nm and an emission wavelength of 453 nm [24].
The metabolites were extracted from the reaction vial with ethyl
actetate at neutral pH and derived with nBuB or TMS for GC-MS
analysis.
The ability of BphC and NahC to oxidize of 1,2-dihydroxydiben-
zofuran and 3,4-dihydroxydibenzofuran was verified in a coupled
reaction with His-tagged-purified BphB. HPLC-purified cis-1,2-dihy-
dro-1,2-dihydroxydibenzofuran or cis-3,4-dihydro-3,4-dihydroxydi-
benzofuran were used as substrate. The activity was measured in
50 mM phosphate buffer (pH 7.0) containing 0.6 nmol BphB, 0.6
nmol His-tagged-purified B-356 BphC, or His-tagged-purified G-7
NahC and 100 nmol NAD in a final volume of 500 l. The enzyme
activity was monitored spectrophotometrically at 462 nm for the
oxidation of 1,2-dihydroxydibenzofuran and at 420 nm for 3,4-dihy-
droxydibenzofuran. For GC-MS analysis of the meta-cleavage me-
tabolites, the assay medium was acidified to pH 3.5 and extracted
with ethyl acetate and treated with TMS for GC-MS analysis.
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